Feb 6, 2026
Which Alzheimer’s treatments are in phase 3 trials with potential 2026 readouts and who are the funders?
Several high‑profile Phase 3 Alzheimer’s trials could report results in 2026, including ’s anti‑amyloid , ’s EVOKE program, ’s pivotal study, the POLARIS‑AD trial of AR1001, and a phase 3 trial; fundi...